arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Alector, Inc.

ALEC
$1.77 ▼ -0.09 (-4.57%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
35 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
49
Health
Weak
Neutral
auto_awesome

Analytical Summary

Alector, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $195.7M
Dividend Yield
Revenue Growth -71.7%
Op. Margin None
ROIC -133.5%
FCF / Share $-0.45
Trailing P/E
Price / Book 18.9x
FCF Yield
Debt / Equity 0.94
info Valuation on last close. End-of-day price, Aug 7, 2026.

35-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.05M
↓ -71.7%
Net Income Profit after all expenses
$-22.93M
↑ +43.3%
Operating Margin Operating profit as % of sales
-433.6%
↓ -3144.0%
FCF / Share Free cash flow per share
$-0.45
↑ +26.2%
Long-Term Debt Long-term obligations
$8.29M
↓ -17.1%

Health Breakdown

Financial Health
36
Cash Quality
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 35 quarters